Sell 2/14/2025Upgraded
Gemina Laboratories Ltd. (GLABF) was upgraded to D- from E+ on 2/14/2025 due to a large increase in the total return index, valuation index and volatility index.

Sell 3/14/2023Downgrade
Gemina Laboratories Ltd. (GLABF) was downgraded to E+ from D- on 03/14/2023.

Sell 2/23/2023Upgraded
Gemina Laboratories Ltd. (GLABF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.

Sell 2/8/2023Downgrade
Gemina Laboratories Ltd. (GLABF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index.

Sell 1/5/2023Upgraded
Gemina Laboratories Ltd. (GLABF) was upgraded to D- from E+ on 1/5/2023 due to a substantial increase in the growth index. Earnings per share increased from -$0.0267 to -$0.015, and EBIT increased 39.22% from -$1.55M to -$940.2.

Sell 12/19/2022Downgrade
Gemina Laboratories Ltd. (GLABF) was downgraded to E+ from D- on 12/19/2022 due to a decline in the volatility index and total return index.

Sell 12/1/2022Upgraded
Gemina Laboratories Ltd. (GLABF) was upgraded to D- from E on 12/01/2022.

Sell 11/16/2022Downgrade
Gemina Laboratories Ltd. (GLABF) was downgraded to E from E+ on 11/16/2022 due to a large decline in the total return index, valuation index and volatility index.

Sell 11/1/2022Upgraded
Gemina Laboratories Ltd. (GLABF) was upgraded to E+ from E on 11/1/2022 due to a noticeable increase in the valuation index and volatility index.

Sell 10/11/2022Downgrade
Gemina Laboratories Ltd. (GLABF) was downgraded to E from E+ on 10/11/2022 due to a significant decline in the volatility index and total return index.

Sell 9/1/2022Upgraded
Gemina Laboratories Ltd. (GLABF) was upgraded to E+ from E on 9/1/2022 due to a significant increase in the total return index.

Sell 6/23/2022None
Gemina Laboratories Ltd. (GLABF) was downgraded to E from U on 06/23/2022.